Related Experiment Videos
[Edrophonium chloride (Tensilon) test: a safe method in diagnosing myasthenia gravis]
H Domanovits1, S Wenger, M Schillinger
1Abteilung für Notfallmedizin, AKH der Stadt Wien, Universitätskliniken, Osterreich. Hans.Domanovits@akh-wien.ac.at
Wiener Klinische Wochenschrift
|August 17, 2000
Summary
The Tensilon test, using edrophonium chloride, is a safe diagnostic procedure for myasthenia gravis. Monitoring hemodynamic and ECG parameters revealed minimal adverse events, supporting its clinical utility.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Myasthenia gravis diagnosis often involves the Tensilon test.
- Edrophonium chloride is used in the Tensilon test.
- Evaluating the safety profile of diagnostic procedures is crucial.
Purpose of the Study:
- To assess the safety of edrophonium chloride during the Tensilon test.
- To monitor hemodynamic and electrocardiographic (ECG) parameters.
- To document adverse events associated with the Tensilon test.
Main Methods:
- An open, prospective study included 25 patients with myasthenia gravis.
- Intravenous edrophonium chloride (Tensilon) was administered.
- Hemodynamic (blood pressure, heart rate) and ECG data were recorded.
- Adverse events were observed for 10 minutes post-administration.
Main Results:
- No significant changes in blood pressure or heart rate were observed.
- One patient on beta-blockers experienced a transient grade I AV block.
- 11 patients reported self-limiting, short-duration adverse events.
- No serious adverse events like syncope or hemodynamic deterioration occurred.
Conclusions:
- The Tensilon test is generally a safe diagnostic procedure.
- Pre-test assessment including cardiac history, medication review, and ECG is recommended.
- Caution is advised for patients with dysrhythmia history on specific medications (digitalis, beta-blockers, Ca antagonists) due to potential enhanced vagal effects.